​​Evolutions in our understanding of endocrine disrupting chemicals during pregnancy​

We are exposed to numerous chemicals throughout our livespans. The most critical window of expsure is pregnancy, a time when not only the developing individual, but also the mother, are extremely sensitive to endocrine disruption The 7 articles contained in this Special Issueopens in new tab/window published in Elsevier’s Molecular and Cellular Endocrinology journal cover environmental and chemical exposures from conception throughout pregnancy.

This collection of articles examines different aspects and effects of environmental and chemical endocrine disruptions during pregnancy. Its ground breaking topics pertain to: effects of temperature and stress on fetal growth, nanoparticles at the maternal-fetal interface, pregnancy related maternal physiological adaptations and fetal chemical exposure, toxicity of prenatal exposures to endocrine disrupting chemicals, toxicity and placental cells, immunological and metabolic status of women exposed to EDCs, animal studies pertaining to placenta-brain axis disruption from chemical exposure.  

Quote from the Comissioning Editor’s: “Pregnancy is among the most vulnerable periods in a woman’s lifetime. It is well established that environmental exposures during pregnancy can have adverse impacts on the maternal-fetal interface with effects spanning the placenta, the fetus, and the mother, at a time during which most of her organs undergo critical adaptations. Most chemicals in addition to bathing the placental bed and having a direct impact on placental function also cross the placental barrier reaching the fetus and posing a developmental risk. This Special Issue assembles a series of works that review the state of the art regarding pregnancy exposures and the impact on maternal-fetal interface that can underlie pregnancy disorders and fetal outcomes.” 

This research addressing the growing need for more nuanced and complex understandings of how our bodies interact with their environments. Nothing could be more fundamental to this interaction than pregnancy itself. While these articles do not paint the entire picture of endocrine distrupting chemicals (EDC) and pregnancy, they do begin a more serious and focused dialogue that should serve as a stepping stone for future advancements in the field.  

The articles contained in this special issue are:

• “Ambient temperature, heat stress and fetal growth: A review of placenta-mediated mechanisms” Whitney Cowell, Natasha Ard, Teresa Herrera, Eleanor A. Medley, Leonardo Trasande (https://doi.org/10.1016/j.mce.2023.112000opens in new tab/window) Molecular and Cellular Endocrinology, volume 576, October 2023, published by Elsevier. 

• “Nanoparticles at the maternal-fetal interface” S. Adams, P.A. Stapleton (https://doi.org/10.1016/j.mce.2023.112067opens in new tab/window) Molecular and Cellular Endocrinology, Article in Press 2023, published by Elsevier. 

• “Pregnancy-related maternal physiological adaptations and fetal chemical exposure” Marie-Therese Vinnars, Marie Bixo, Pauliina Damdimopoulou  (https://doi.org/10.1016/j.mce.2023.112064opens in new tab/window) Molecular and Cellular Endocrinology, volume 578, December 2023, published by Elsevier. 

• “Prenatal exposures to endocrine disrupting chemicals: The role of multi-omics in understanding toxicity” Margaret H. Rabotnick, Jessa Ehlinger, Ariana Haidari, Jaclyn M. Goodrich (https://doi.org/10.1016/j.mce.2023.112046opens in new tab/window) Molecular and Cellular Endocrinology, volume 578, December 2023, published by Elsevier. 

• “Placental single cell transcriptomics: Opportunities for endocrine disrupting chemical toxicology” Elana R. Elkin, Kyle A. Campbell, Samantha Lapehn, Sean M. Harris, ... Alison G. Paquette (https://doi.org/10.1016/j.mce.2023.112066opens in new tab/window) Molecular and Cellular Endocrinology, Article in Press 2023, published by Elsevier. 

• “Exposure to endocrine disrupting chemicals impacts immunological and metabolic status of women during pregnancy” Alyssa K. Merrill, Marissa Sobolewski, Martha Susiarjo (https://doi.org/10.1016/j.mce.2023.112031opens in new tab/window) Molecular and Cellular Endocrinology, volume 577, November 2023, published by Elsevier. 

• “Gestational exposure to FireMaster® 550 (FM 550) disrupts the placenta-brain axis in a socially monogamous rodent species, the prairie vole (Microtus ochrogaster)” William P. Marinello, Sagi Enicole A. Gillera, Yoonhee Han, Jason R. Richardson, ... Heather B. Patisaul (https://doi.org/10.1016/j.mce.2023.112041opens in new tab/window) Molecular and Cellular Endocrinology, volume 576, October 2023, published by Elsevier. 

Copies of these papers are available to credentialed journalists upon request; please contact ​Daniel Martin​ at ​[email protected]​   

 About ​Molecular and Cellular Endocrinology (MCE)​ 

Molecular and Cellular Endocrinology was established in 1974 to meet the demand for integrated publication on all aspects related to the genetic and biochemical effects, synthesis and secretions of extracellular signals (hormones, neurotransmitters, etc.) and to the understanding of cellular regulatory mechanisms involved in hormonal control. 

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.